Table 3.
Stepwise multivariable linear regression models for CMR EF1
| Model 1 (r2 0.06) n = 137 | Model 2 (r2 0.07) n = 117 | Model 3 (r2 0.07) n = 117 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | 95% CI | p value | Coefficient | 95% CI | p value | Coefficient | 95% CI | p value | |
| Zva | − 0.44 | − 0.79, − 0.09 | < 0.05 | − 0.35 | − 0.73, 0.04 | ns | − 0.32 | − 0.71, 0.08 | ns |
| iECV | − 0.26 | − 0.57, 0.04 | ns | − 0.31 | − 0.69, 0.07 | ns | − 0.34 | − 0.74, 0.05 | ns |
| Infarct LGE | − 0.01 | − 0.32, 0.32 | ns | − 0.05 | − 0.39, 0.29 | ns | − 0.07 | − 0.42, 0.28 | ns |
| Hs-cTnI | 0.01 | − 0.10, 0.11 | ns | 0.01 | − 0.09, 0.12 | ns | |||
| BNP | − 0.02 | − 0.11, 0.07 | ns | − 0.01 | − 0.10, 0.09 | ns | |||
| Age per 10 years | − 0.03 | − 0.14, 0.09 | ns | ||||||
| Male | 0.06 | − 0.20, 0.33 | ns | ||||||
Zva, iECV, hs-cTnI and BNP were log2-transformed
Zva aortic impedance, iECV indexed extracellular volume, LGE late gadolinium enhancement, hs-cTnI high sensitive cardiac troponin I, BNP brain natriuretic peptide